Assignee
FENG HANPING
US·5 granted patents·2 pending applications·6 citations·filing 2009–2022
Top patents by PatentIndex Score
7 records- 0179US11466075B2Yeast-based immunotherapy against clostridium difficile infectionFENG HANPING·Filed 2016·Granted Oct 11, 2022·2 cites·12 claims
- 0274US12384833B2Yeast-based immunotherapy against Clostridium difficile infectionFENG HANPING·Filed 2022·Granted Aug 12, 2025·0 cites·12 claims
- 0370US8206940B2Methods for diagnosis of Clostridium difficile and methods and vectors for recombinant toxin expressionFENG HANPING·Filed 2009·Granted Jun 26, 2012·4 cites·13 claims
- 0450US12077575B2Humanized tetra-specific octavalent antibody against clostridium difficile toxin A and BFENG HANPING·Filed 2020·Granted Sep 3, 2024·0 cites·19 claims
- 0542US2012276132A1Atoxic recombinant holotoxins of Clostridium difficile as immunogensFENG HANPING·Filed 2012·Application pending·0 cites
- 0636US2019111001A1Microparticulate system for colonic drug deliveryFENG HANPING·Filed 2017·Application pending·0 cites
- 0731US10961299B2Tetra-specific, octameric binding agents and antibodies against Clostridium difficile toxin A and toxin B for treatment of C. difficile infectionFENG HANPING·Filed 2016·Granted Mar 30, 2021·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →